It is at this point, if it has established a broader international customer base, that it will become increasingly attractive as an acquisition target itself. For its new investors, while an exit is far from front-of-mind at this stage, in comparison with an ongoing and expensive battle to maintain and grow to the next level of competition versus some of the leading healthcare technology vendors on the planet, a payday in five to ten years’ time could be the most likely long-term outcome.

About the author: Steve Holloway is principal analyst for Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry. Signify's major coverage areas are Healthcare IT, Medical Imaging and Digital Health. Our clients include technology vendors, healthcare providers and payers, management consultants and investors. Signify Research is headquartered in Cranfield, U.K.

Back to HCB News

Business Affairs Homepage